Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy
PHASE1CompletedINTERVENTIONAL
Enrollment
8
Participants
Timeline
Start Date
August 6, 2014
Primary Completion Date
July 31, 2015
Study Completion Date
September 15, 2015
Conditions
HNSCC
Interventions
DRUG
Taxotere, Cisplatin, Afatinib
Trial Locations (1)
34298
ICM Val d'Aurelle, Montpellier, Montpellier
All Listed Sponsors
lead
Groupe Oncologie Radiotherapie Tete et Cou
OTHER
NCT02216617 - Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemotherapy | Biotech Hunter | Biotech Hunter